Resource Use, Costs and Clinical Outcomes among COPD Patients Who Initiate Therapy with Tiotropium/Olodaterol or Fluticasone Furoate/Umeclidinium/Vilanterol

S. Sethi, S. Palli, L. Bengtson, E. Buysman, B. Clark, A. Sargent, A. Shaikh, G.T. Ferguson
{"title":"Resource Use, Costs and Clinical Outcomes among COPD Patients Who Initiate Therapy with Tiotropium/Olodaterol or Fluticasone Furoate/Umeclidinium/Vilanterol","authors":"S. Sethi, S. Palli, L. Bengtson, E. Buysman, B. Clark, A. Sargent, A. Shaikh, G.T. Ferguson","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4854","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":429370,"journal":{"name":"C102. USING ANALOG OR TECHNOLOGY TOOLS TO EVALUATE AND INTERVENE TO IMPROVE HEALTHCARE DELIVERY","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"C102. USING ANALOG OR TECHNOLOGY TOOLS TO EVALUATE AND INTERVENE TO IMPROVE HEALTHCARE DELIVERY","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4854","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
COPD患者开始使用噻托溴铵/奥替特罗或糠酸氟替卡松/乌莫利维尼/维兰特罗治疗的资源使用、成本和临床结果
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信